Tracked deals
3
3 tracked deals across 2022-2026.
Stamford, Connecticut, United States
Nexus Health is a market access consultancy and part of The Lockwood Group. It provides pharmaceutical and biotechnology clients with services across coverage, pricing and reimbursement, trade and distribution, patient services, evidence planning and generation, value communications, payer marketing, data and analytics, and policy and advocacy. Its 2026 acquisition of Stratis Group expanded its commercialization strategy, analytics, and patient support capabilities.
Tracked deals
3
3 tracked deals across 2022-2026.
Recent pace
1
1 tracked deal announced in the last 12 months.
Deal mix
Buyout
2 buyout · 1 addon
Last 3 years
Supporting Data
Nexus Health, part of The Lockwood Group, acquired Stratis Group, a commercialization strategy and market access consulting firm for pharmaceutical, biotechnology, and physician network clients. The deal expands Nexus Health’s integrated, data-driven capabilities across patient services, HEOR, real-world evidence, adherence strategy, and field reimbursement management.
The Lockwood Group has acquired Research To Practice (RTP), a Miami-based provider of accredited oncology-focused medical education. The acquisition expands The Lockwood Group's healthcare services platform capabilities in oncology education, continuing medical education formats, and global clinical insights.
The Lockwood Group, a Stamford-based medical communications agency, has acquired Random42, a London-based medical animation and scientific communications studio, from private equity firm Graphite Capital. The acquisition expands Lockwood's creative capabilities (animation, VR/AR, interactive experiences) and extends Random42's geographic footprint, particularly into the U.S. market.
Turn tracked acquisition activity into an outreach-ready buyer list.